Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SHENZHEN, China, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology...
-
HONG KONG, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced...
-
WISeKey to showcase “INeS” a fully-fledged PKI-as-a-service solution supporting MATTER standard, at the upcoming SIDO Paris 2022 IoT Exhibition GENEVA – November 8, 2022: WISeKey International...
-
SHANGHAI, China, Nov. 08, 2022 (GLOBE NEWSWIRE) -- 360 DigiTech, Inc. (NASDAQ: QFIN) ("360 DigiTech" or the "Company"), a leading financial technology platform in China, today announced that it will...
-
CHICAGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (Nasdaq: FSRD) (“Fast Radius'' or the “Company”) announced today that it is launching an in-court process to effectuate one or more...
-
SHANGHAI, China, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Today, Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun” or the “Company”), a leading brand e-commerce solution provider and digital commerce...
-
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
-
First-in-human data shared at The Liver Meeting® 2022 supported a favorable safety and tolerability profile for INT-787 in healthy adults Company announces severe alcohol-associated hepatitis (sAH),...
-
Press release Cambridge, MA U.S.A. (November 7, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics...
-
2022 earnings guidance increased and narrowed to a range of $2.76 - $2.83 per shareProvided 2023 earnings guidance range of $2.82 - $2.96 and 2023 annual common stock dividend target of $1.81Increased...